Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies

Popat, Sanjay; Ahn, Myung-Ju; Ekman, Simon; Leighl, Natasha B.; Ramalingam, Suresh S.; Reungwetwattana, Thanyanan; Siva, Shankar; Tsuboi, Masahiro; Wu, Yi-Long; Yang, James Chih-Hsin

doi:10.1007/s11523-023-00947-9

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies

Correction
Published: 08 February 2023

Volume 18, page 311, (2023)
Cite this article

Download PDF

Targeted Oncology Aims and scope Submit manuscript

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies

Download PDF

Sanjay Popat ORCID: orcid.org/0000-0003-2087-4963^1,2,
Myung-Ju Ahn³,
Simon Ekman^4,5,
Natasha B. Leighl⁶,
Suresh S. Ramalingam⁷,
Thanyanan Reungwetwattana⁸,
Shankar Siva^9,10,
Masahiro Tsuboi¹¹,
Yi-Long Wu¹² &
…
James Chih-Hsin Yang¹³

2653 Accesses
Explore all metrics

The Original Article was published on 18 January 2023

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Targeted Oncology https://doi.org/10.1007/s11523-022-00941-7

While typesetting the articles the formatting of the Tables was incorrect. Now this has been corrected.

The original article has been corrected.

Author information

Authors and Affiliations

Lung Unit, Royal Marsden Hospital, London, UK
Sanjay Popat
Division of Clinical Studies, Institute of Cancer Research, London, UK
Sanjay Popat
Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Myung-Ju Ahn
Theme Cancer, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden
Simon Ekman
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Simon Ekman
Medical Oncology, Princess Margaret Cancer Center, Toronto, Canada
Natasha B. Leighl
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Suresh S. Ramalingam
Division of Medical Oncology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand
Thanyanan Reungwetwattana
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Shankar Siva
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
Shankar Siva
Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Masahiro Tsuboi
Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
Yi-Long Wu
Department of Oncology, National Taiwan University Hospital Cancer Center, Taipei, Taiwan
James Chih-Hsin Yang

Authors

Sanjay Popat
View author publications
You can also search for this author in PubMed Google Scholar
Myung-Ju Ahn
View author publications
You can also search for this author in PubMed Google Scholar
Simon Ekman
View author publications
You can also search for this author in PubMed Google Scholar
Natasha B. Leighl
View author publications
You can also search for this author in PubMed Google Scholar
Suresh S. Ramalingam
View author publications
You can also search for this author in PubMed Google Scholar
Thanyanan Reungwetwattana
View author publications
You can also search for this author in PubMed Google Scholar
Shankar Siva
View author publications
You can also search for this author in PubMed Google Scholar
Masahiro Tsuboi
View author publications
You can also search for this author in PubMed Google Scholar
Yi-Long Wu
View author publications
You can also search for this author in PubMed Google Scholar
James Chih-Hsin Yang
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay Popat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Popat, S., Ahn, MJ., Ekman, S. et al. Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies. Targ Oncol 18, 311 (2023). https://doi.org/10.1007/s11523-023-00947-9

Download citation

Published: 08 February 2023
Issue Date: March 2023
DOI: https://doi.org/10.1007/s11523-023-00947-9

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation